Main Article Content

Abstract

Background: Semarang is one of the cities in Central Java with the highest positive number and mortality rate of Covid-19. It became the largest contributor to daily cases in Central Java. In general, the severity of Covid-19 in Semarang is 5.3% and increased to 24% in the elderly. Mortality Covid-19 was caused by various factors such as demographic and non-demographic factors.
Objective: This study aims to determine the impact of several risk factors of COVID-19 mortality in Semarang.
Methods: This is an analytical cross-sectional study. Data analysis was carried out analytically with a binary logistic regression test. The sample used was the total population of 32.555 confirmed positive from March 2020 to March 2021 registered in Semarang Health Office.
Results: The results demonstrated that mortality due to Covid-19 in Semarang was frequent in the elderly (27.3%), males (9.4%), had comorbidities such as diabetes mellitus (28.6%), kidney disease (43.5%), neuromuscular (36.4%), and cancer (29.3%), and accompanied by symptoms such as Dyspnea (18.1%), weakness/lethargy (19.9%), and fever (14.6%).
Conclusion: Age, gender, travel history, comorbidities (kidney, neuromuscular, cancer, and diabetes mellitus), and symptoms (fever, shortness of breath, and weakness/lethargy) are risk factors for mortality Covid-19 in Semarang.

Keywords

Covid-19 Comorbidity Symptoms Travel History Mortality

Article Details

Author Biographies

Rita Laila Wulandari, Faculty of Public Health, Universitas Diponegoro, Semarang

Faculty of Public Health, Universitas Diponegoro, Semarang

Cahya Tri Purnami, Faculty of Public Health, Universitas Diponegoro, Semarang

Faculty of Public Health, Universitas Diponegoro, Semarang

Farid Agushybana, Faculty of Public Health, Universitas Diponegoro, Semarang

Faculty of Public Health, Universitas Diponegoro, Semarang

Atik Mawarni, Faculty of Public Health, Universitas Diponegoro, Semarang

Faculty of Public Health, Universitas Diponegoro, Semarang

How to Cite
Wulandari, R. L., Purnami, C. T. ., Agushybana, F. ., & Mawarni, A. . (2022). The influence of demography, travel history and comorbidity toward the mortality incidence due to Covid-19 in Semarang. JKKI : Jurnal Kedokteran Dan Kesehatan Indonesia, 13(2), 149–159. https://doi.org/10.20885/JKKI.Vol13.Iss2.art7

References

  1. Abdelhafiz AS, Mohammed Z, Ibrahim ME, Ziady HH, Alorabi M, Ayyad M, et al. Knowledge, Perceptions, and Attitude of Egyptians Towards the Novel Coronavirus Disease (COVID-19). J Community Health [Internet]. 2020;45(5):881–90. Available from: https://doi.org/10.1007/s10900-020-00827-7
  2. Mansuri FMA, Zalat MM, Khan AA, Alsaedi EQ, Ibrahim HM. Estimating the public response to mitigation measures and self-perceived behaviors towards the COVID-19 pandemic. J Taibah Univ Med Sci. 2020 Aug 1;15(4):278–83.
  3. Shi Y, Wang J, Yang Y, Wang Z, Wang G, Hashimoto K, et al. Knowledge and attitudes of medical staff in Chinese psychiatric hospitals regarding COVID-19. Brain, Behav Immun - Heal [Internet]. 2020;4(March):100064. Available from: https://doi.org/10.1016/j.bbih.2020.100064
  4. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med. 2020;382(10):929–36.
  5. Covid-19. Peta Sebaran Covid-19. Gugus Tugas Percepatan Penanganan Covid-19 [Internet]. 2020;119:1–7. Available from: https://covid19.go.id/peta-sebaran
  6. Dinas Kesehatan Kota Semarang. Data Sebaran COVID-19 [Internet]. Available from: https://siagacorona.semarangkota.go.id/halaman/covid19
  7. Elimian KO, Ochu CL, Ebhodaghe B, Myles P, Crawford EE, Igumbor E, et al. Patient characteristics associated with COVID-19 positivity and fatality in Nigeria: Retrospective cohort study. BMJ Open. 2020;10(12):1–16.
  8. Barek MA, Aziz MA, Islam MS. Impact of age, sex, comorbidities and clinical symptoms on the severity of COVID-19 cases: A meta-analysis with 55 studies and 10014 cases. Heliyon. 2020;6(12):1–24.
  9. Lu L, Zhong W, Bian Z, Li Z, Zhang K, Liang B, et al. A comparison of mortality-related risk factors of COVID-19, SARS, and MERS: A systematic review and meta-analysis. J Infect. 2020;81(4):e18–25.
  10. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762–8.